Phio Pharmaceuticals Scraps Share Sale to Triton Funds
Company Announcements

Phio Pharmaceuticals Scraps Share Sale to Triton Funds

An update from Phio Pharmaceuticals (PHIO) is now available.

Phio Pharmaceuticals Corp. had an agreement to sell nearly 96,000 shares to Triton Funds LP, which could have brought in over $600,000 for Phio. However, when the stock’s price dropped below the agreed price, Phio backed out, deciding it was in their best interest to seek other financial options. No shares were exchanged before the deal was terminated, and this development was publicly announced in a recent press release.

Find detailed analytics on PHIO stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskPhio Pharmaceuticals Names New VP and CFO
TheFlyPhio Pharmaceuticals files to sell 1.13M shares of common stock for holders
TheFlyPhio Pharmaceuticals Corp trading resumes
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App